Axogen, Inc.

Axogen, Inc.AXGNEarnings & Financial Report

Nasdaq · Health Care · Electromedical & Electrotherapeutic Apparatus

Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering (IPO). Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is...

Top Holders

Holder% OwnedSharesChangeAs of
First Light Asset Management, LLC9.96%
4.4M
2024-11-07
BlackRock, Inc.7.80%
3.3M
2024-01-26
NOS. OF ABOVE PERSONS6.80%
3.0M
▲ +0.80pp2024-11-14
ArrowMark Colorado Holdings, LLC6.14%
2.7M
-5.83pp2024-09-10
The Vanguard Group5.73%
2.5M
2024-02-13

Insider Transactions

Net 90d: $171.5K · buys $0 / sells $171.5K
Range:
Action:
Role:
InsiderRoleAction
2026-03-16DeVinney Erick WayneChief Innovation OfficerOption exercise
6.4K
$0.00$0
2026-03-16DeVinney Erick WayneChief Innovation OfficerOption exercise
11.6K
$0.00$0
2026-03-16DeVinney Erick WayneChief Innovation OfficerSell (open market)
5.2K
$32.84$171.5K
2026-03-16Hartley Lindsey MarieCFOOption exercise
4.0K
$0.00$0
2026-03-16Hartley Lindsey MarieCFOOption exercise
5.0K
$0.00$0
2026-03-01Began Marc AEVP & General CounselOption exercise
11.3K
$0.00$0
2026-02-26DeVinney Erick WayneChief Innovation OfficerGrant
33.8K
$0.00$0
2026-02-26Jens KempChief Marketing OfficerGrant
50.7K
$0.00$0
2026-02-26Began Marc AEVP & General CounselGrant
33.8K
$0.00$0
2026-02-26Hartley Lindsey MarieCFOGrant
17.5K
$0.00$0
110 of 11
Page 1 / 2